Skip to main content

Table 2 Crude and Adjusted Relative Risks for unfavorable TB treatment outcomes (death, treatment failure, or loss to follow-up) compared to favorable TB treatment outcomes 

From: Is distance associated with tuberculosis treatment outcomes? A retrospective cohort study in Kampala, Uganda

 

Crude RR (95% CI)

Adjusted RR (95% CI)

Euclidean Distance

  < 2 km

Reference

Reference

 2 to < 5 km

0.88 (0.69, 1.12)

0.91 (0.70, 1.17)

 5 to < 10 km

0.82 (0.63, 1.06)

0.88 (0.68, 1.15)

  > 10 km

0.76 (0.56, 1.02)

0.77 (0.57, 1.04)

Age at diagnosis

 0–14 years

0.42 (0.20, 0.87)

0.44 (0.21, 0.90)

 15–24 years

0.63 (0.46, 0.87)

0.79 (0.57, 1.08)

 25–34 years

Reference

Reference

 35–44 years

1.03 (0.80, 1.32)

0.97 (0.75, 1.25)

 45–54 years

1.35 (1.02, 1.77)

1.18 (0.89, 1.57)

 55–64 years

1.25 (0.79, 1.98)

1.23 (0.79, 1.92)

  > 65 years

1.96 (1.25, 3.06)

2.53 (1.59, 4.04)

Male sex

1.12 (0.92, 1.36)

1.08 (0.88, 1.32)

HIV Positive

1.83 (1.50, 2.24)

1.72 (1.36, 2.17)

Pulmonary TB

0.85 (0.66, 1.10)

1.06 (0.80, 1.40)

Lack of bacteriologic confirmation

1.47 (1.22, 1.78)

1.57 (1.27, 1.94)

Treatment Start year

 2014

Reference

Reference

 2015

0.89 (0.71, 1.12)

0.88 (0.70, 1.11)

 2016

0.86 (0.69, 1.09)

0.89 (0.71, 1.11)

Facility

 Kisugu Health Center (public)

Reference

Reference

 Alive Medical Services

1.19 (0.93, 1.53)

0.97 (0.74, 1.27)

 International Hospital Kampala

0.99 (0.70, 1.40)

0.84 (0.59, 1.20)

 Kibuli Muslim Hospital

1.01 (0.72, 1.40)

0.97 (0.70, 1.35)

 St. Francis Hospital - Nsambya

0.63 (0.48, 0.83)

0.60 (0.45, 0.80)

 Meeting Point

0.76 (0.21, 2.72)

0.55 (0.15, 2.03)